Statement of financial position

3

Fixed assets

231 

Current assets

9,086 

Creditors: amounts falling due within one year

6,129 

The average number of persons employed, including directors, during the year was 2 (2025: 2).

For the period ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.

The financial statements were approved by the board of directors on 20 October 2026 and signed on behalf of the board by:

....................... Alexander Marcus Seifalian Director

....................... Hana Salussolia Director

Company Registration Number 09096454 The company is a private company limited by shares, which is incorporated in England and Wales (no 09096454). The address of the registered office is London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH.